Patent Number: 6,251,910

Title: 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists

Abstract: Compounds of formula having the following stereochemistry ##STR1## wherein R, R.sup.1, R.sub.2, R.sup.3 and R.sup.4 are as defined in the specification. The compounds are useful as P.sub.2T receptor antagonists.

Inventors: Guile; Simon (Loughborough, GB), Ingall; Anthony (Loughborough, GB), Springthorpe; Brian (Loughborough, GB), Willis; Paul (Nottingham, GB)

Assignee: AstraZeneca UK Limited

International Classification: C07D 487/00 (20060101); C07D 487/04 (20060101); C07D 487/04 (); A61K 031/519 (); A61P 007/02 ()

Expiration Date: 06/26/2018